Their approach promises a permanent cure and potential for protection against HIV
The HIV-1 virus has proved to be tenacious, inserting its genome permanently into its victims’ DNA, forcing patients to take a lifelong drug regimen to control the virus and prevent a fresh attack. Now, a team of Temple University School of Medicine researchers has designed a way to snip out the integrated HIV-1 genes for good.
“This is one important step on the path toward a permanent cure for AIDS,” says Kamel Khalili, PhD, Professor and Chair of the Department of Neuroscience at Temple. Khalili and his colleague, Wenhui Hu, MD, PhD, Associate Professor of Neuroscience at Temple, led the work which marks the first successful attempt to eliminate latent HIV-1 virus from human cells. “It’s an exciting discovery, but it’s not yet ready to go into the clinic. It’s a proof of concept that we’re moving in the right direction,” added Dr. Khalili, who is also Director of the Center for Neurovirology and Director of the Comprehensive NeuroAIDS Center at Temple.
In a study published July 21 by the Proceedings of the National Academy of Sciences, Khalili and colleagues detail how they created molecular tools to delete the HIV-1 proviral DNA. When deployed, a combination of a DNA-snipping enzyme called a nuclease and a targeting strand of RNA called a guide RNA (gRNA) hunt down the viral genome and excise the HIV-1 DNA. From there, the cell’s gene repair machinery takes over, soldering the loose ends of the genome back together – resulting in virus-free cells.
“Since HIV-1 is never cleared by the immune system, removal of the virus is required in order to cure the disease,” says Khalili, whose research focuses on the neuropathogenesis of viral infections. The same technique could theoretically be used against a variety of viruses, he says.
The research shows that these molecular tools also hold promise as a therapeutic vaccine; cells armed with the nuclease-RNA combination proved impervious to HIV infection.
Worldwide, more than 33 million people have HIV, including more than 1 million in the United States. Every year, another 50,000 Americans contract the virus, according to the U.S. Centers for Disease Control and Prevention.
The Latest on: HIV
via Google News
The Latest on: HIV
- East Bay commits to ending HIV/AIDS epidemic in the Bay Area, especially among the homeless communityon July 19, 2019 at 7:16 pm
OAKLAND, Calif. (KGO) -- The head of the Centers for Disease Control was on the ground in Oakland on Friday to assess the HIV/AIDS epidemic in Alameda County. AIDS is still very much a threat in ... […]
- Should HIV-positive workers be allowed in the sex industry? Some advocates say yeson July 19, 2019 at 5:14 pm
This article originally appeared in In These Times. Individuals who are HIV-positive are not permitted to participate in the adult entertainment industry. That standard is enforced through the ... […]
- HIV therapies have little effect on a baby’s brain developmenton July 19, 2019 at 6:36 am
An almost certain death sentence 30 years ago, having HIV today has lost its fatal sting. In just over 20 years, the development of Antiretroviral Therapies, or ART, has ensured that deadly outcomes ... […]
- Exploiting the CCR5 Receptor: Potential Avenue for HIV Cure?on July 19, 2019 at 6:30 am
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out Cancel ... […]
- Market for HIV Prevention Drugs May More Than Double, Citi Sayson July 19, 2019 at 5:41 am
Even with approval approaching for a generic of the first medicine to prevent HIV, the U.S. market for similar medicines may more than double by 2030, a Citi analyst predicts. Sales for HIV prevention ... […]
- Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapyon July 19, 2019 at 2:23 am
Perinatally-acquired HIV has persistent effects on long-term health outcomes, even after early treatment. We hypothesize that epigenetic indicators, such as DNA methylation, may elucidate cellular ... […]
- Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ARTon July 19, 2019 at 2:22 am
The HIV-1 reservoir is the major hurdle to a cure. We here evaluate viral and host characteristics associated with reservoir size and long-term dynamics in 1,057 individuals on suppressive ... […]
- Nigeria: HIV Rate Among Nigeria Prisoners Double That of General Population - UN Studyon July 18, 2019 at 10:18 pm
People in Nigerian prisons are two times more likely to be living with HIV than people in the general community, a new study has revealed. According to a National HIV Assessment Study, HIV among ... […]
- Tooth Wear in Patients Treated With HIV Anti-retroviral Therapyon July 18, 2019 at 9:24 pm
Background: The objective of this study was to elucidate the relationship between HIV anti-retroviral therapy and tooth wear. Methods: Assessment of tooth wear was conducted both with a survey ... […]
- Results Vary for HIV 'Test-and-Treat' Programs in Africaon July 18, 2019 at 2:12 pm
Universal test-and-treat programs, where patients are tested and then immediately offered treatment for HIV, have produced variable results in Africa, and ultimately may not go far enough, a ... […]
via Bing News